Part 3 of this series for Global Biosimilars Week, penned by Dracey Poore, director of biosimilars at Cardinal Health, ...

Valued at a market cap of $30.3 billion, Dublin, Ohio-based Cardinal Health, Inc. (CAH) is a healthcare services and products ...

As breast cancer awareness month concludes, I want to remind you that awareness and advocacy should not be limited to just ...

Cardinal Health has entered into definitive agreements to acquire two companies as the medical supply firm and drug ...

Cardinal Health CAH recently announced that it has entered into definitive agreements to acquire two companies. These ...

Court Square Capital Partners has agreed to sell Advanced Diabetes Supply Group, a Carlsbad, California-based distributor of durable medical equipment specializing in diabetes supplies, to Cardinal ...

A Baltimore jury found two drug distributors liable for contributing to the city's ongoing opioid crisis. The decision came ...

Wells Fargo analyst Steve Baxter maintained a Sell rating on Cardinal Health (CAH – Research Report) yesterday and set a price target of $101.00. The company’s shares closed yesterday at $123.51.

Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on Cardinal Health (CAH – Research Report). The associated price target remains the same with $127.00. Erin Wright has given his ...

Cardinal Health plans acquisitions to anchor its new territory managing specialty physician groups and expand its home-care ...

Cardinal Health has agreed to acquire a majority stake in GI Alliance, a gastroenterology management services organization, and Advanced Diabetes Supply Group for a combined total of $3.9 billion, ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...